- Home
- DNLI vs ASGN Comparison
DNLI vs ASGN Comparison
Compare DNLI & ASGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ASGN
- Stock Information
- Founded
- DNLI 2013
- ASGN 1985
- Country
- DNLI United States
- ASGN United States
- Employees
- DNLI N/A
- ASGN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ASGN Professional Services
- Sector
- DNLI Health Care
- ASGN Consumer Discretionary
- Exchange
- DNLI Nasdaq
- ASGN Nasdaq
- Market Cap
- DNLI 2.1B
- ASGN 2.3B
- IPO Year
- DNLI 2017
- ASGN 1992
- Fundamental
- Price
- DNLI $14.19
- ASGN $51.45
- Analyst Decision
- DNLI Strong Buy
- ASGN Hold
- Analyst Count
- DNLI 16
- ASGN 6
- Target Price
- DNLI $33.62
- ASGN $61.67
- AVG Volume (30 Days)
- DNLI 2.0M
- ASGN 514.8K
- Earning Date
- DNLI 11-05-2025
- ASGN 10-22-2025
- Dividend Yield
- DNLI N/A
- ASGN N/A
- EPS Growth
- DNLI N/A
- ASGN N/A
- EPS
- DNLI N/A
- ASGN 3.15
- Revenue
- DNLI N/A
- ASGN $4,004,900,000.00
- Revenue This Year
- DNLI N/A
- ASGN N/A
- Revenue Next Year
- DNLI $802.87
- ASGN $2.42
- P/E Ratio
- DNLI N/A
- ASGN $16.34
- Revenue Growth
- DNLI N/A
- ASGN N/A
- 52 Week Low
- DNLI $10.57
- ASGN $46.64
- 52 Week High
- DNLI $33.33
- ASGN $101.66
- Technical
- Relative Strength Index (RSI)
- DNLI 41.95
- ASGN 47.11
- Support Level
- DNLI $14.63
- ASGN $50.74
- Resistance Level
- DNLI $15.69
- ASGN $54.89
- Average True Range (ATR)
- DNLI 0.68
- ASGN 1.68
- MACD
- DNLI -0.14
- ASGN -0.21
- Stochastic Oscillator
- DNLI 0.99
- ASGN 17.11
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.